British Columbia BioEvolution 2008: Sponsor and join the evolution...Last chance

British Columbia BioEvolution depicts company technology licensing relationships with the province's universities and non-profit research organizations -- the economic engines supporting innovative research and development.

British Columbia BioEvolution is a one-of-a-kind genealogy chart that illustrates the founding "technology origins" of more than 80 biotechnology and medical device firms located in the province of British Columbia. Sponsorships start at just $250.

Washington State Biomedical Device Summit May 15...Register today!

WBBA is collaborating with several organizations to host the 2008 Washington State Biomedical Device Summit. Focused solely on the region’s medical device sector, the May 15 Summit will attract 200 executives from the medical device industry, researchers, economic development professionals and media.

The event will feature a report on key findings of a study about the sector, a panel discussion with executives from the region’s industry, the launch of the Biomedical Device Innovation Partnership Zone, a showcase medical device products developed or being developed in Washington state and a reception. WBBA’s partners on this effort are enterpriseSeattle, the Economic Development Council of Snohomish County, City of Bothell, University of Washington Bothell, the Prosperity Partnership and the Washington Technology Industry Association (WTIA). The event is Thursday, May 15 from 4 to 7 pm, at the UW Washington Bothell, WA.

Local News...

Free News Release Posting & Archiving Service


• BioMS Medical provides update on pipeline products  BioMS Medical announced an update on its pipeline products, HYC750 and development with BioCyDex. The Company has entered into a Royalty and Assignment Agreement with Orcrist Bio. for HYC750.
  BioMS Medical Corp.  May 09, 2008  
  
  
• Bayer and Regeneron start additional Phase 3 Study for VEGF Trap-Eye  Bayer HealthCare and development partner Regeneron Pharmaceuticals announced that the first patient has been dosed in the new VIEW 2 trial, a second Phase 3 clinical study in a development program evaluating VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration.
  Bayer  May 08, 2008  
  
  
• Zevalin revenues lead Cell Therapeutics's first quarter 2008 financial results  Cell Therapeutics reported financial results for the quarter ended March 31, 2008. Total revenues for the quarter were $3.4 million compared to $20,000 for the first quarter of 2007. Gross product sales of Zevalin(R) (Ibritumomab Tiuxetan) reached $3.8 million in the first quarter of 2008.
  Cell Therapeutics, Inc.  May 08, 2008  
  
  
• AstraZeneca submits sNDA for Seroquel XR for the treatment of generalised anxiety disorder  AstraZeneca announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration for SEROQUEL XR(TM) Extended-Release Tablets to seek approval for the treatment of generalised anxiety disorder, including maintenance of antianxiety effect.
  AstraZeneca  May 08, 2008  
  
  
• Dendreon reports first quarter 2008 financial results  Dendreon reported results for the first quarter ended March 31, 2008. Revenue for the first quarter of 2008 was $31,000 compared to $80,000 for the quarter ended March 31, 2007.
  Dendreon Corporation  May 08, 2008  
  
  

More... | Submit News Release | National News

New Job Postings...

Free Job Posting Trial Offer

• Director, Project Operations Centre for Drug Research and Development (BC)
• Director, Business Development Centre for Drug Research and Development (BC)
• Senior Manager, Preclinical Development Inimex Pharmaceuticals Inc. (BC)
• Senior CMC Project Manager CMC ICOS Biologics (WA)
• Quality Assurance-GMP Compliance Associate IV CMC ICOS Biologics (WA)

More... | Job Advertising... | About Job Postings...

Upcoming Events...

Free Event Posting Service

• 05/12/2008: World Pharmaceutical Congress
• 05/12/2008: Advertising, Promotion and Labeling Conference
• 05/12/2008: Generic, Supergenerics & Patent Strategies
• 05/12/2008: SBRI Seminar
• 05/13/2008: 2008 Health Care Conference

More... | Submit Event | Event Advertising...